TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
82,647
|
74,776
|
79,044 |
Financial expenses |
1
|
0
|
1 |
Earnings before taxes |
3,578
|
3,149
|
2,205 |
EBITDA |
3,433
|
3,116
|
2,236 |
Total assets |
19,369
|
25,366
|
23,150 |
Current assets |
19,069
|
25,047
|
22,787 |
Current liabilities |
3,632
|
11,090
|
9,100 |
Equity capital |
15,458
|
14,006
|
13,767 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
49
|
48
![]() |
48 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
79.8%
|
55.2%
|
59.5% |
Turnover per employee |
1,687
|
1,558
|
1,647 |
Profit as a percentage of turnover |
4.3%
|
4.2%
|
2.8% |
Return on assets (ROA) |
18.5%
|
12.4%
|
9.5% |
Current ratio |
525.0%
|
225.9%
|
250.4% |
Return on equity (ROE) |
23.1%
|
22.5%
|
16.0% |
Change turnover |
7,653
|
2,134
|
-37 |
Change turnover % |
10%
|
3%
|
0% |
Chg. No. of employees |
1
|
0
|
-5 |
Chg. No. of employees % |
2%
|
0%
|
-9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.